CRISPR Therapeutics AG Quarterly Common Stock, Shares, Outstanding from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CRISPR Therapeutics AG quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2015 to Q2 2024.
  • CRISPR Therapeutics AG Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 85M shares, a 7.15% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 85M +5.67M +7.15% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 84.8M +5.97M +7.58% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 80M +1.53M +1.95% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 79.4M +1.18M +1.51% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 79.4M +1.58M +2.03% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 78.9M +1.48M +1.91% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 78.5M +1.52M +1.98% Dec 31, 2022 10-K 2024-02-21
Q3 2022 78.2M +1.78M +2.33% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 77.8M +1.71M +2.25% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 77.4M +1.66M +2.19% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 77M +3.08M +4.16% Dec 31, 2021 10-K 2023-02-21
Q3 2021 76.5M +5.86M +8.3% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 76.1M +13.5M +21.6% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 75.7M +14.8M +24.4% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 73.9M +13.1M +21.6% Dec 31, 2020 10-K 2022-02-15
Q3 2020 70.6M +15.4M +27.9% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 62.6M +9.05M +16.9% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 60.9M +8.25M +15.7% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 60.8M +8.93M +17.2% Dec 31, 2019 10-K 2021-02-16
Q3 2019 55.2M +3.63M +7.05% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 53.5M +6.43M +13.7% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 52.6M +5.95M +12.8% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 51.9M +11.3M +27.7% Dec 31, 2018 10-K 2020-02-12
Q3 2018 51.6M +11.2M +27.7% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 47.1M +7.03M +17.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 46.7M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 40.6M +873K +2.2% Dec 31, 2017 10-K 2019-02-25
Q3 2017 40.4M +35.1M +661% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 40M Jun 30, 2017 10-Q 2017-08-10
Q4 2016 39.7M +34.2M +619% Dec 31, 2016 10-K 2018-03-08
Q3 2016 5.31M Sep 30, 2016 10-Q 2016-11-22
Q4 2015 5.53M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.